The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is (7.11) USD. With the latest stock price at 119.39 USD, the upside of Repligen Corp based on DCF is -106.0%.
Based on the latest price of 119.39 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 106.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.0% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (17.10) - (4.07) | (7.11) |
| Upside | -114.3% - -103.4% | -106.0% |